The Truth About Premature Ejaculation Treatments No One Told You

Premature Ejaculation Breakthroughs: New Science Reveals Surprising Treatment Paths

premature ejaculation treatments including dapoxetine and emerging therapies like cligosiban.

Oral medications like dapoxetine are among the most researched treatments for premature ejaculation./ Pexels

Premature ejaculation (PE)—a condition affecting a significant proportion of men—remains the subject of intensive scientific research. Recent drug developments and clinical studies are challenging old notions and opening doors to new approaches.

What Is Premature Ejaculation?

PE is defined by ejaculation that always or nearly always occurs within about one minute of vaginal penetration

Dapoxetine: The Only Approved Oral Drug for PE

Dapoxetine, marketed as Priligy, is a fast‑acting SSRI developed expressly for on‑demand use before sexual activity. It has approval across 50+ countries and significantly increases intravaginal ejaculatory latency time (IELT).

Main trial (12 weeks): baseline IELT ~0.9 min; rose to ~2.78 min (30 mg) and ~3.32 min (60 mg), compared to ~1.75 min for placebo (p<0 .0001="" li="">
Common side effects: nausea (8.7–20%), dizziness, diarrhea, headache. Higher rates at 60 mg.
Discontinuation rates may be high (>80% in long‑term real‑world use), often due to cost, side effects, or unmet expectations.

Dapoxetine’s short half‑life (1.5–1.6 h) and rapid absorption allow single‑use dosing with low accumulation risk.

Cligosiban: An Oxytocin Receptor Antagonist on the Horizon

Cligosiban (also known as IX‑01)—a brain‑penetrant, selective oxytocin receptor antagonist—is under development to delay ejaculation via central pathways.

PEPIX Study (Proof‑of‑Concept, Phase IIa, early 2019)

In the PEPIX trial on men with lifelong PE, cligosiban increased IELT by about 61 s versus 16.4 s for placebo over 4 weeks (p = 0.0086), with good tolerability and improvements in patient‑reported outcomes.

PEDRIX Study (Phase IIb, mid‑2019)

A larger randomized placebo‑controlled trial (up to 1200 mg doses) failed to show a statistically significant increase in IELT. Cligosiban remained well tolerated, but the efficacy signal did not replicate.

The divergent results may reflect dose, patient selection, or methodology differences. Further Phase III trials would be required.

Other Investigational Agents and Strategies

Epelsiban, a peripheral‐acting oxytocin antagonist, failed to demonstrate clinical efficacy in oral dosing despite promising animal studies; its inability to cross the blood‑brain barrier appears to be a factor.

Other off‑label pharmacological approaches include:

Topical local anesthetics (e.g. lidocaine, prilocaine): reduce penile sensitivity, modestly lengthen IELT.
Tramadol: an opioid analgesic sometimes used off‑label; side effects and dependency limit its use, but in some trials it lengthened ejaculation latency.
Other SSRIs or TCAs (e.g. paroxetine, sertraline): daily use can delay ejaculation significantly, but require weeks to act and carry long‑term side effect risks like weight gain or libido decrease.

Behavioral Techniques and Combined Approaches

Stop‑start and squeeze techniques, pelvic floor (Kegel) exercises, and condom use remain common first‑line approaches. Research confirms improved IELT and satisfaction when behavioral therapy is combined with pharmacotherapy, versus either alone.

Summary Comparison Table

Treatment	Approach	Typical IELT Effect	Side Effects	Status
Dapoxetine (30–60 mg)	On‑demand SSRI	≈3× baseline (~2.8–3.3 min)	Nausea, dizziness, headache	Approved in many countries
Cligosiban (IX‑01)	Oxytocin antagonist	~60 s increase in one trial; failed in larger study	Generally well tolerated	Phase II—further trials needed
Epelsiban	Peripheral OT antagonist	No significant benefit	Minimal	Abandoned for PE
Other SSRIs/TCA (daily)	Daily dosing	2–9× baseline	Sexual dysfunction, weight gain	Off‑label use
Tramadol (off‑label)	Opioid mechanism	Modest IELT prolongation	Dependence, sedation	Off‑label; limited use

Hormonal Factors: The Role of Testosterone

Associations between testosterone levels and PE are not consistent. Some studies suggest high testosterone may be associated with PE (TT ≈ 4.97 ng/mL vs ~4.13–4.34 in controls), but others show no correlation. Low testosterone is more strongly linked with erectile dysfunction than PE; however, selective patients with low T have sometimes seen benefit from testosterone modulation.

What It All Means: A Clinician’s Perspective

Dapoxetine remains the most evidence‑backed and approved option for many men, delivering fast‑onset benefits with predictable side‑effect profiles. Cligosiban offered intriguing early promise, but at present lacks consistent Phase IIb confirmation. Untested or off‑label methods may offer help, but carry higher risk or uncertainty.

Combining behavioral strategies with pharmacotherapy offers synergistic improvement for many.

FAQ

Is dapoxetine safe?

Generally yes, when used as directed (30–60 mg up to once every 24 hours). Common mild side effects include nausea, dizziness, headache, diarrhea. Long‑term discontinuation rates are high for multiple reasons. Use should be reviewed by a physician.

Is cligosiban available yet?

No. Cligosiban is still investigational (Phase II). While one early study (PEPIX) showed efficacy, the larger Phase IIb PEDRIX failed to replicate results. It is not currently approved or available.

Do behavioral methods actually help?

Yes. Stop‑start, squeeze, pelvic‑floor exercises and condom use can modestly delay ejaculation. Effects are greater when behavior is combined with medication.

Can testosterone treatment help?

Not routinely. Hormone modulation may help only in specifically identified cases of low or high testosterone; evidence is inconsistent.

Are there risks in using other SSRIs for PE?

Yes. While fluoxetine, paroxetine or sertraline can delay ejaculation significantly, they require daily dosing for several weeks and carry cumulative side effects like sexual dysfunction, weight gain and mood disturbances. They are not approved specifically for PE.

ZenHealth Tips